-
EP2366381
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2366381
| EP2366381 - Phenylephrine pharmaceutical formulations and compositions for colonic absorption [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 17.08.2012 Database last updated on 06.11.2024 | Most recent event Tooltip | 17.08.2012 | Application deemed to be withdrawn | published on 19.09.2012 [2012/38] | Applicant(s) | For all designated states MSD Consumer Care, Inc. 3030 Jackson Avenue Memphis TN 38151 / US | [2011/38] | Inventor(s) | 01 /
Monteith, David 14 Pleasant View Manor Road Pittstown, NJ 08867 / US | 02 /
O'Mullane, John 8 Grove Place Mountain Lakes, NJ 07046 / US | 03 /
Reo, Joseph P. 4325 Cool Springs Cove Lakeland, TN 38002 / US | 04 /
Nowak, Robert T. 30 Barberry Lane New Providence, NJ 07974 / US | 05 /
Wan, Jiansheng 201 Briant Park Drive Springfield, NJ 07081 / US | 06 /
Kabir, Mohammed A. 10225 Mays Glad Drive Lakeland, TN 38002 / US | 07 /
Abutarif, Malaz A. 57 Jared Drive North Brunswick, NJ 08902 / US | 08 /
Fritz, Glenn E. 8807 Brunswick Farms Drive Arlington, TN 38005 / US | [2011/38] | Representative(s) | Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB Beselerstraße 4 22607 Hamburg / DE | [N/P] |
| Former [2011/38] | UEXKÜLL & STOLBERG Patentanwälte Beselerstrasse 4 22607 Hamburg / DE | Application number, filing date | 11158570.9 | 01.06.2007 | [2011/38] | Priority number, date | US20060810021P | 01.06.2006 Original published format: US 810021 P | US20060874830P | 14.12.2006 Original published format: US 874830 P | [2011/38] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2366381 | Date: | 21.09.2011 | Language: | EN | [2011/38] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 24.08.2011 | Classification | IPC: | A61K9/22, A61K9/36, A61K31/137 | [2011/38] | CPC: |
A61K31/137 (EP,KR,US);
A61K9/28 (KR);
A61K31/4545 (EP,US);
A61K47/12 (US);
A61K47/38 (US);
A61K9/167 (US);
A61K9/2054 (EP,US);
A61K9/209 (EP,US);
A61K9/48 (KR);
A61K9/5026 (US);
A61K9/5042 (US);
A61P11/00 (EP);
A61P11/02 (EP);
A61P27/14 (EP);
A61P31/16 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR [2011/38] | Extension states | AL | 21.03.2012 | BA | 21.03.2012 | HR | 21.03.2012 | MK | 21.03.2012 | RS | 21.03.2012 | Title | German: | Pharmazeutische Phenylephrin-Formulierungen und Zusammensetzungen zur Absorption im Darm | [2011/38] | English: | Phenylephrine pharmaceutical formulations and compositions for colonic absorption | [2011/38] | French: | Formulations pharmaceutiques de phényléphrine et compositions pour absorption du côlon | [2011/38] | Examination procedure | 21.03.2012 | Examination requested [2012/18] | 22.03.2012 | Application deemed to be withdrawn, date of legal effect [2012/38] | 02.05.2012 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time [2012/38] | Parent application(s) Tooltip | EP07777373.7 / EP2034970 | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20070777373) is 16.03.2009 | Fees paid | Renewal fee | 18.04.2011 | Renewal fee patent year 03 | 18.04.2011 | Renewal fee patent year 04 | 18.04.2011 | Renewal fee patent year 05 | 31.03.2012 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]US3558768 (KLIPPEL KENNETH R) [X] 1-20 * claim 1 * * example 3 *; | [A]US3851051 (CONNOR E, et al) [A] 1-20* the whole document *; | [X]US2005095288 (HONEA DICKEY [US]) [X] 1-20 * paragraph [0003] * * paragraph [0022] - paragraph [0026] * * paragraph [0038] - paragraph [0063] * * examples 7,10 *; | [I]US2006057205 (SRINIVASAN VISWANATHAN [US], et al) [I] 1-20 * example 19 *; | [A] - HAMDANI JAMILA ET AL, "Development and evaluation of prolonged release pellets obtained by the melt pelletization process", INTERNATIONAL JOURNAL OF PHARMACEUTICS (KIDLINGTON), (20021001), vol. 245, no. 1-2, ISSN 0378-5173, pages 167 - 177, XP002484422 [A] 1-20 * abstract * * paragraph [02.4] * DOI: http://dx.doi.org/10.1016/S0378-5173(02)00348-4 | by applicant | BE647043 | US3326924 | US3419565 | US3878217 | US4219559 | US4282233 | US4369184 | US4525358 | US5595997 | US7163696 | - K. GUMBHIR, "An Investigation of Pharmacokinetics of Phenylephrine and its Metabolites in Humans", PHD DISSERTATION IN PHARMACEUTICAL SCIENCES | - K. GUMBHIR; W. D. MASON, "Determination of m-hydroxymandelic acid, m-hydroxyphenylglycol and their conjugates in human plasma using liquid chromatography with electrochemical detection", JOURNAL OFPHARMACEUTICAL AND BIOMEDICAL ANALYSIS, (1994), vol. 12, pages 943 - 949 | - J. H. HENGSTMANNAND; J. GORONZY., "Pharmacokinetics of 3H-Phenylephrine in Man", EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, (1982), vol. 21, pages 335 - 341 | - V. VUMAAND; I. KANFER, "High- performance liquid chromatographic determination of phenylephrine in human serum with coulometric detection", JOURNAL OF CHROMATOGRAPHY, (1996), vol. 678, doi:doi:10.1016/0378-4347(95)00487-4, pages 245 - 252, XP004044053 DOI: http://dx.doi.org/10.1016/0378-4347(95)00487-4 | - M. YAMAGUCHI; H. MONJI; 1. AOKI; T. YASHIKI, "High Performance liquid chromatographic determination of phenylephrine in human serum using coulometric switching flourescence detection", JOURNAL OF CHROMATOGRAPHY B., (1994), vol. 661, pages 93 - 99 | - A. STOCKIS; X. DEROUBAIX; B. JEANBAPTISTE; R. LINS; A. M. ALLEMON; H. LAUFEN, "Relative Bioavailability of Carbinoxamine and Phenylephrine from a Retard Capsule after Single and Repeated Dose Adminstration in Healthy Subjects", ARZNEIM.-FORSCH.LDRUG RES., (1995), vol. 45, pages 1009 - 1012 | - A. MARTINSSON; S. BEVEGåRD; P. HJEMDAHL, "Analysis of Phenylephrine in Plasma: Initial Data About Concentration-Effect Releationship", EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, (1986), vol. 30, pages 427 - 431 | - PATEL ET AL., DRUG DELIVERY TECHNOL, (200607), vol. 6, no. 7, pages 62 - 71 | - TANNO ET AL., DRUG DEV IND PHARM, (200401), vol. 30, no. 1, pages 9 - 17 | - BRONDSTED ET AL., PHARMACEUTICAL RES, (199212), vol. 9, no. 12, pages 1540 - 1545 | - SIEW ET AL., AAPS PHARMSCI1ECH, (2000), vol. 1, no. 3, page 22 | - TULEU ET AL., ALIMENTARY PHARMACOL THERAPEUT, (200210), vol. 16, no. 10, page 1771 | - CHAUBAL, DRUG DELIVERY TECHNOL | - CHENG ET AL., WORLD J GASTROENTEROL, (2004), vol. 10, no. 12, pages 1769 - 1774 | - ASGHAR ET AL., J PHARM PHARMACEUT SCI, (2006), pages 327 - 338 | - LI ET AL., AAPSPHARMSCITECH, (2002), vol. 3, no. 4 |